The adjustment in price target by UBS suggests a slightly more positive outlook on Moelis & Company's valuation, despite maintaining a Sell rating. This could indicate an expectation of some improvement in the company's performance or market conditions, but not enough to change the overall bearish stance. Investors might see this as a nuanced view, potentially leading to mixed reactions in the short term.